These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 26080829)

  • 21. Inducing cell proliferation inhibition, apoptosis, and motility reduction by silencing long noncoding ribonucleic acid metastasis-associated lung adenocarcinoma transcript 1 in urothelial carcinoma of the bladder.
    Han Y; Liu Y; Nie L; Gui Y; Cai Z
    Urology; 2013 Jan; 81(1):209.e1-7. PubMed ID: 23153939
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The tumor suppressor maspin mediates E2F1-induced sensitivity of cancer cells to chemotherapy.
    Ben Shachar B; Feldstein O; Hacohen D; Ginsberg D
    Mol Cancer Res; 2010 Mar; 8(3):363-72. PubMed ID: 20197383
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Suppression of insulin-like growth factor-1 receptor by RNA interference inhibits cell growth in vitro and induces chemosensitization of HO8910PM cell to cisplatin].
    Gao H; Shi J; Ge SF; DI W
    Zhonghua Fu Chan Ke Za Zhi; 2008 Jan; 43(1):45-9. PubMed ID: 18366933
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dual inhibitor of phosphoinositide 3-kinase/mammalian target of rapamycin NVP-BEZ235 effectively inhibits cisplatin-resistant urothelial cancer cell growth through autophagic flux.
    Li JR; Cheng CL; Yang CR; Ou YC; Wu MJ; Ko JL
    Toxicol Lett; 2013 Jul; 220(3):267-76. PubMed ID: 23651616
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aberrant DNA methylation of T-cell leukemia, homeobox 3 modulates cisplatin sensitivity in bladder cancer.
    Tada Y; Yokomizo A; Shiota M; Tsunoda T; Plass C; Naito S
    Int J Oncol; 2011 Sep; 39(3):727-33. PubMed ID: 21617853
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dickkopf-3 (Dkk3) induces apoptosis in cisplatin-resistant lung adenocarcinoma cells via the Wnt/β-catenin pathway.
    Wang Z; Ma LJ; Kang Y; Li X; Zhang XJ
    Oncol Rep; 2015 Mar; 33(3):1097-106. PubMed ID: 25573172
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interference with the expression of β-catenin reverses cisplatin resistance in A2780/DDP cells and inhibits the progression of ovarian cancer in mouse model.
    Zhao H; Wei W; Sun Y; Gao J; Wang Q; Zheng J
    DNA Cell Biol; 2015 Jan; 34(1):55-62. PubMed ID: 25211326
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synergistic antitumor effect of triptolide and cisplatin in cisplatin resistant human bladder cancer cells.
    Ho JN; Byun SS; Lee S; Oh JJ; Hong SK; Lee SE; Yeon JS
    J Urol; 2015 Mar; 193(3):1016-22. PubMed ID: 25229559
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Akt promotes cisplatin resistance in human ovarian cancer cells through inhibition of p53 phosphorylation and nuclear function.
    Fraser M; Bai T; Tsang BK
    Int J Cancer; 2008 Feb; 122(3):534-46. PubMed ID: 17918180
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transcribed ultraconserved region Uc.63+ promotes resistance to cisplatin through regulation of androgen receptor signaling in bladder cancer.
    Sekino Y; Sakamoto N; Ishikawa A; Honma R; Shigematsu Y; Hayashi T; Sentani K; Oue N; Teishima J; Matsubara A; Yasui W
    Oncol Rep; 2019 May; 41(5):3111-3118. PubMed ID: 30864720
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IGFBP2 modulates the chemoresistant phenotype in esophageal adenocarcinoma.
    Myers AL; Lin L; Nancarrow DJ; Wang Z; Ferrer-Torres D; Thomas DG; Orringer MB; Lin J; Reddy RM; Beer DG; Chang AC
    Oncotarget; 2015 Sep; 6(28):25897-916. PubMed ID: 26317790
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Up-regulation of Bfl-1/A1 via NF-kappaB activation in cisplatin-resistant human bladder cancer cell line.
    Kim JK; Kim KD; Lee E; Lim JS; Cho HJ; Yoon HK; Cho MY; Baek KE; Park YP; Paik SG; Choe YK; Lee HG
    Cancer Lett; 2004 Aug; 212(1):61-70. PubMed ID: 15246562
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exogenous mutant p53 DNA enhanced cisplatin-induced apoptosis in TSGH-8301 human bladder cancer cells.
    Chang FL; Ling YF; Lai MD
    Anticancer Res; 2000; 20(1A):329-36. PubMed ID: 10769676
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of Bcl-2 on apoptosis and transcription factor NF-κB activation induced by adriamycin in bladder carcinoma BIU87 cells.
    Zhang GJ; Zhang Z
    Asian Pac J Cancer Prev; 2013; 14(4):2387-91. PubMed ID: 23725146
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Upregulation of Bcl-2 is associated with cisplatin-resistance via inhibition of Bax translocation in human bladder cancer cells.
    Cho HJ; Kim JK; Kim KD; Yoon HK; Cho MY; Park YP; Jeon JH; Lee ES; Byun SS; Lim HM; Song EY; Lim JS; Yoon DY; Lee HG; Choe YK
    Cancer Lett; 2006 Jun; 237(1):56-66. PubMed ID: 16009487
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The influence and mechanisms of purple sweet potato anthocyanins on the growth of bladder cancer BIU87 cell].
    Li WL; Ji GH; Zhang XZ; Yu HY
    Zhonghua Yi Xue Za Zhi; 2018 Feb; 98(6):457-459. PubMed ID: 29429260
    [No Abstract]   [Full Text] [Related]  

  • 37. ERCC1 siRNA ameliorates drug resistance to cisplatin in gastric carcinoma cell lines.
    Li W; Jie Z; Li Z; Liu Y; Gan Q; Mao Y; Wang X
    Mol Med Rep; 2014 Jun; 9(6):2423-8. PubMed ID: 24699918
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential regulation of bladder cancer growth by various glucocorticoids: corticosterone and prednisone inhibit cell invasion without promoting cell proliferation or reducing cisplatin cytotoxicity.
    Ishiguro H; Kawahara T; Zheng Y; Kashiwagi E; Li Y; Miyamoto H
    Cancer Chemother Pharmacol; 2014 Aug; 74(2):249-55. PubMed ID: 24880571
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multikinase inhibitor motesanib enhances the antitumor effect of cisplatin in cisplatin‑resistant human bladder cancer cells via apoptosis and the PI3K/Akt pathway.
    Ho JN; Byun SS; Lee SE; Youn JI; Lee S
    Oncol Rep; 2019 Apr; 41(4):2482-2490. PubMed ID: 30816494
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [An experimental study of bladder cancer cell apoptosis induced by cinobufacin].
    Su J; Xu ZJ; Ye MS
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2009 Apr; 25(4):351-3. PubMed ID: 19351510
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.